Loading clinical trials...
Loading clinical trials...
A Phase II Study of Docetaxel, Oxaliplatin and S-1 (DOS) in Patients With Advanced Gastric Cancer
Conditions
Interventions
DOS (Docetaxel, Oxaliplatin and S-1)
Locations
2
South Korea
Hallym University Medical Center
Anyang, South Korea
Asan Medical Center
Seoul, South Korea
Start Date
August 1, 2007
Primary Completion Date
June 1, 2010
Completion Date
June 1, 2010
Last Updated
September 21, 2012
NCT06885697
NCT06630130
NCT07035587
NCT01649271
NCT02310230
NCT06260150
Lead Sponsor
Hallym University Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions